Regional Network of Excellence
TESA - Trials of Excellence in Southern Africa
TESA network was launched in 2009, to strengthen clinical research capacities in Southern Africa, as well as to increase North-South South-South networks among member institutions
Newsroom
TAGENDI II Coordinators and Fellows Meeting Set for April 2025
The EDCTP-TESA III: TAGENDI II Coordinators’ and Fellows Meeting is scheduled to take place on 3rd – 4th April 2025...
Genomic Study Uncovers High Genetic Diversity in Drug-Resistant Tuberculosis in Botswana
An innovative study using whole genome sequencing (WGS) has revealed significant genetic diversity among rifampicin-resistant Mycobacterium tuberculosis (M. tb) strains...
Twelfth EDCTP Forum: Call for Abstracts and Scientific Symposia Open
Download a detailed Call for Abstracts and Scientific Symposia Advert below:
Bonolo Phinius graduates with PhD in Medical Sciences
Dr Bonolo Bonita Phinius, a TESA III sponsored PhD Fellow at the Botswana Harvard Health Partnership (BHP), has graduated with...
Call for Applications for the TAGENDI PhD and MPhil Fellowship Program
Download a detailed Call for Applications Advert and the Application Form below: Fellowship Advert Application Form
TESA delivers Clinical Research Associates (CRA) Training on Clinical Trials Monitoring
Six trainees from three Trials of Excellence in Southern Africa (TESA) sites recently received a five-day practical Clinical Research Associates...
TESA Holds High-Level Scientific Session and Streering Committee Meeting
The Trials of Excellence in Southern Africa (TESA) convened a two-day scientific session and steering committee meeting from 8-9 May...
Research Publications
- Differential RD-1-specific IFN-γ host responses to diverse Mycobacterium tuberculosis strains in HIV-uninfected persons may be explained by genotypic variation in the ESX-1 region
- Bcells and their regulatory functions during Tuberculosis: Latency and active disease
- Linezolid interruption in patients with fluoroquinolone-resistant tuberculosis receiving a bedaquiline-based treatment regimen
- A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug-resistant tuberculosis
- Correlation of High Interleukin 17A and Interleukin 6 Levels with High Virus Load Among Subtype C HIV-infected, Antiretroviral Therapy-naive Zimbabwean Patients: A Cross-sectional Study
- The World Health Organization Recommended TB Diagnostic Tools
- The changing treatment landscape for MDR/XDR-TB — Can current clinical trials revolutionise and inform a brave new world?
SCIENTIST OF THE MONTH
Dr Sikhulile Moyo wins MLK International Humanitarian Service Award
The Botswana Harvard AIDS Institute Partnership (BHP) Laboratory Director, Dr Sikhulile Moyo has been accorded a Martin Luther King Honoree International Humanitarian Service Award at the 32nd Annual Rev. Dr Martin Luther King, Jr Celebration hosted by Rainbow PUSH Coalition and Rev Jesse L. Jackson.
Read More
